Published in J Neurosurg on April 01, 2009
Treatment of Brain Metastases. J Clin Oncol (2015) 1.03
Surgical outcomes of hemorrhagic metastatic brain tumors. Cancer Res Treat (2011) 0.99
Risks of postoperative paresis in motor eloquently and non-eloquently located brain metastases. BMC Cancer (2014) 0.90
Controversies in the management of brain metastases. Surg Neurol Int (2013) 0.87
The tumour is not enough or is it? Problems and new concepts in the surgery of cerebral metastases. Ecancermedicalscience (2013) 0.82
The metastatic infiltration at the metastasis/brain parenchyma-interface is very heterogeneous and has a significant impact on survival in a prospective study. Oncotarget (2015) 0.81
Clinical use of diffusion tensor image-merged functional neuronavigation for brain tumor surgeries: review of preoperative, intraoperative, and postoperative data for 123 cases. Yonsei Med J (2014) 0.79
Outcome of surgical resection of symptomatic cerebral lesions in non-small cell lung cancer patients with multiple brain metastases. Brain Tumor Res Treat (2013) 0.79
Surgery for brain metastases. Surg Neurol Int (2013) 0.79
Preservation of neurocognitive function and local control of 1 to 3 brain metastases treated with surgery and carmustine wafers. Cancer (2013) 0.79
A Fluorescence-Guided Laser Ablation System for Removal of Residual Cancer in a Mouse Model of Soft Tissue Sarcoma. Theranostics (2016) 0.78
5-ALA fluorescence of cerebral metastases and its impact for the local-in-brain progression. Oncotarget (2016) 0.78
Methods and results of locoregional treatment of brain metastases in patients with non-small cell lung cancer. Contemp Oncol (Pozn) (2016) 0.75
Intraoperative neuromonitoring for function-guided resection differs for supratentorial motor eloquent gliomas and metastases. BMC Neurol (2015) 0.75
Surgical Resection of Non-Glial Tumors in the Motor Cortex. Brain Tumor Res Treat (2016) 0.75
Efficacy and Safety of Fractionated Stereotactic Radiosurgery for Large Brain Metastases. J Korean Neurosurg Soc (2015) 0.75
Supra-complete surgery via dual intraoperative visualization approach (DiVA) prolongs patient survival in glioblastoma. Oncotarget (2016) 0.75
Use of diffusion-weighted MRI to modify radiosurgery planning in brain metastases may reduce local recurrence. J Neurooncol (2016) 0.75
The Current and Future Treatment of Brain Metastases. Front Surg (2016) 0.75
The Efficacy of Postoperative Chemotherapy for Patients with Metastatic Brain Tumors from Non-Small Cell Lung Cancer. Brain Tumor Res Treat (2015) 0.75
Application of fluorescein sodium in the resection of vermis pilocytic astrocytomas. World J Surg Oncol (2017) 0.75
Intraoperative 5-aminolevulinic acid-induced photodynamic diagnosis of metastatic brain tumors with histopathological analysis. World J Surg Oncol (2017) 0.75
The influence of intraoperative resection control modalities on survival following gross total resection of glioblastoma. Neurosurg Rev (2016) 0.75
International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol (2011) 21.49
Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial. Lancet Oncol (2010) 5.51
Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol (2005) 5.31
Improved quality of life outcomes after laparoscopy-assisted distal gastrectomy for early gastric cancer: results of a prospective randomized clinical trial. Ann Surg (2008) 4.95
Intercalated combination of chemotherapy and erlotinib for patients with advanced stage non-small-cell lung cancer (FASTACT-2): a randomised, double-blind trial. Lancet Oncol (2013) 4.20
First-SIGNAL: first-line single-agent iressa versus gemcitabine and cisplatin trial in never-smokers with adenocarcinoma of the lung. J Clin Oncol (2012) 3.90
Comprehensive analysis of UGT1A polymorphisms predictive for pharmacokinetics and treatment outcome in patients with non-small-cell lung cancer treated with irinotecan and cisplatin. J Clin Oncol (2006) 2.69
A terahertz metamaterial with unnaturally high refractive index. Nature (2011) 2.62
Cancer statistics in Korea: incidence, mortality and survival in 2005. J Korean Med Sci (2009) 2.61
Stroke statistics in Korea: part I. Epidemiology and risk factors: a report from the korean stroke society and clinical research center for stroke. J Stroke (2013) 2.19
Frequency and mechanisms of stroke recurrence after cryptogenic stroke. Ann Neurol (2003) 2.06
Variation in TP63 is associated with lung adenocarcinoma susceptibility in Japanese and Korean populations. Nat Genet (2010) 1.90
Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int J Pharm (2004) 1.88
Treatment of former smokers with 9-cis-retinoic acid reverses loss of retinoic acid receptor-beta expression in the bronchial epithelium: results from a randomized placebo-controlled trial. J Natl Cancer Inst (2003) 1.75
Influenza vaccine coverage rates and perceptions on vaccination in South Korea. J Infect (2007) 1.69
Proliferative changes in the bronchial epithelium of former smokers treated with retinoids. J Natl Cancer Inst (2007) 1.58
Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancer. Radiology (2005) 1.57
Decision analysis for prophylactic cranial irradiation for patients with small-cell lung cancer. J Clin Oncol (2006) 1.57
Conventional enhancement CT: a valuable tool for evaluating pial collateral flow in acute ischemic stroke. Cerebrovasc Dis (2011) 1.56
A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma. J Nucl Med (2008) 1.54
Angiogenesis in ischemic tissue produced by spheroid grafting of human adipose-derived stromal cells. Biomaterials (2011) 1.51
Mitochondrial and nucleocytoplasmic isoforms of O-linked GlcNAc transferase encoded by a single mammalian gene. Arch Biochem Biophys (2003) 1.49
EZH2 generates a methyl degron that is recognized by the DCAF1/DDB1/CUL4 E3 ubiquitin ligase complex. Mol Cell (2012) 1.48
Relative and absolute risks of cigarette smoking on major histologic types of lung cancer in Korean men. Cancer Epidemiol Biomarkers Prev (2005) 1.41
Technical feasibility and safety of laparoscopy-assisted total gastrectomy in gastric cancer: a comparative study with laparoscopy-assisted distal gastrectomy. J Surg Oncol (2009) 1.41
Comparisons of 30-day mortalities and 90-day functional recoveries after first and recurrent primary intracerebral hemorrhage attacks: a multiple-institute retrospective study. World Neurosurg (2012) 1.40
Increased expression of a disintegrin and metalloprotease 8 in allergic rhinitis. Am J Rhinol Allergy (2011) 1.39
Gefitinib as a first-line therapy of advanced or metastatic adenocarcinoma of the lung in never-smokers. Clin Cancer Res (2005) 1.37
Long-term delivery enhances in vivo osteogenic efficacy of bone morphogenetic protein-2 compared to short-term delivery. Biochem Biophys Res Commun (2008) 1.37
Epidemiology of primary brain and central nervous system tumors in Korea. J Korean Neurosurg Soc (2010) 1.29
Associations of ABCB1, ABCC2, and ABCG2 polymorphisms with irinotecan-pharmacokinetics and clinical outcome in patients with advanced non-small cell lung cancer. Cancer (2007) 1.27
Comparison of clinical outcome of patients with non-small-cell lung cancer harbouring epidermal growth factor receptor exon 19 or exon 21 mutations. J Clin Pathol (2011) 1.23
Circulating cell-free DNA in plasma of never smokers with advanced lung adenocarcinoma receiving gefitinib or standard chemotherapy as first-line therapy. Clin Cancer Res (2011) 1.23
Cigarette smoking and cancer incidence risk in adult men: National Health Insurance Corporation Study. Cancer Detect Prev (2004) 1.23
Long-term outcomes of laparoscopy-assisted distal gastrectomy for early gastric cancer: result of a randomized controlled trial (COACT 0301). Surg Endosc (2013) 1.22
Silencing of microRNA-21 confers radio-sensitivity through inhibition of the PI3K/AKT pathway and enhancing autophagy in malignant glioma cell lines. PLoS One (2012) 1.20
Comparison of circulating plasma DNA levels between lung cancer patients and healthy controls. J Mol Diagn (2009) 1.19
Obstructive sleep apnea as a risk factor for cerebral white matter change in a middle-aged and older general population. Sleep (2013) 1.19
Association of p53 codon 72 polymorphism and MDM2 SNP309 with clinical outcome of advanced nonsmall cell lung cancer. Cancer (2008) 1.18
KRIBB11 inhibits HSP70 synthesis through inhibition of heat shock factor 1 function by impairing the recruitment of positive transcription elongation factor b to the hsp70 promoter. J Biol Chem (2010) 1.18
Early neutrophil-to-lymphocyte ratio reduction as a surrogate marker of prognosis in never smokers with advanced lung adenocarcinoma receiving gefitinib or standard chemotherapy as first-line therapy. J Cancer Res Clin Oncol (2012) 1.18
A genome-wide association study reveals susceptibility variants for non-small cell lung cancer in the Korean population. Hum Mol Genet (2010) 1.17
Integrated pharmacogenetic prediction of irinotecan pharmacokinetics and toxicity in patients with advanced non-small cell lung cancer. Lung Cancer (2008) 1.15
Magnetic-field-controlled reconfigurable semiconductor logic. Nature (2013) 1.14
A randomized phase II study of bortezomib and pemetrexed, in combination or alone, in patients with previously treated advanced non-small-cell lung cancer. Lung Cancer (2009) 1.11
Stroke Statistics in Korea: Part II Stroke Awareness and Acute Stroke Care, A Report from the Korean Stroke Society and Clinical Research Center For Stroke. J Stroke (2013) 1.11
Early prediction of response to first-line therapy using integrated 18F-FDG PET/CT for patients with advanced/metastatic non-small cell lung cancer. J Thorac Oncol (2009) 1.11
Is the new seventh AJCC/UICC staging system appropriate for patients with gastric cancer? J Am Coll Surg (2011) 1.11
A randomized phase II trial of S-1-oxaliplatin versus capecitabine-oxaliplatin in advanced gastric cancer. Eur J Cancer (2012) 1.11
FX: an RNA-Seq analysis tool on the cloud. Bioinformatics (2012) 1.10
The reliability and validity of the Korean version of the Epworth sleepiness scale. Sleep Breath (2010) 1.10
Trends in Cancer Screening Rates among Korean Men and Women: Results from the Korean National Cancer Screening Survey (KNCSS), 2004-2010. Cancer Res Treat (2011) 1.09
Single-dose versus fractionated stereotactic radiotherapy for brain metastases. Int J Radiat Oncol Biol Phys (2010) 1.08
A phase II study of sunitinib in patients with relapsed or refractory small cell lung cancer. Lung Cancer (2012) 1.07
Genomic profile analysis of diffuse-type gastric cancers. Genome Biol (2014) 1.07
Hypoxia-induced methylation of a pontin chromatin remodeling factor. Proc Natl Acad Sci U S A (2011) 1.06
Positive conversion of negative signaling of CTLA4 potentiates antitumor efficacy of adoptive T-cell therapy in murine tumor models. Blood (2012) 1.06
Craniospinal irradiation techniques: a dosimetric comparison of proton beams with standard and advanced photon radiotherapy. Int J Radiat Oncol Biol Phys (2010) 1.05
Influence of the organic anion-transporting polypeptide 1B1 (OATP1B1) polymorphisms on irinotecan-pharmacokinetics and clinical outcome of patients with advanced non-small cell lung cancer. Lung Cancer (2007) 1.05
[A study of immune response to hepatitis B vaccine & HBV DNA in isolated anti-HBc positive subjects]. J Prev Med Public Health (2005) 1.04
Clinical characteristics of malignant pericardial effusion associated with recurrence and survival. Cancer Res Treat (2010) 1.02
Validation study of portable device for the diagnosis of obstructive sleep apnea according to the new AASM scoring criteria: Watch-PAT 100. Acta Otolaryngol (2010) 1.01
Galantamine administration in chronic post-stroke aphasia. J Neurol Neurosurg Psychiatry (2012) 1.00
Locally delivered growth factor enhances the angiogenic efficacy of adipose-derived stromal cells transplanted to ischemic limbs. Stem Cells (2009) 1.00
Real-time and non-invasive optical imaging of tumor-targeting glycol chitosan nanoparticles in various tumor models. Biomaterials (2011) 1.00
Dose-volumetric parameters of acute esophageal toxicity in patients with lung cancer treated with three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys (2005) 1.00
The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non-small cell lung cancer. J Thorac Cardiovasc Surg (2012) 0.99
Surgical outcomes of hemorrhagic metastatic brain tumors. Cancer Res Treat (2011) 0.99
Neurological picture. Repetitive internal carotid artery compression of the hyoid: a new mechanism of golfer's stroke? J Neurol Neurosurg Psychiatry (2010) 0.97
Genetic polymorphisms in the polycomb group gene EZH2 and the risk of lung cancer. J Thorac Oncol (2010) 0.95
Analysis of treatment outcomes of intraventricular chemotherapy in 105 patients for leptomeningeal carcinomatosis from non-small-cell lung cancer. J Thorac Oncol (2013) 0.95
Cross-cultural adaptation of the korean version of the minneapolis-manchester quality of life instrument-adolescent form. J Korean Med Sci (2013) 0.95
Therapeutic hypothermia after recanalization in patients with acute ischemic stroke. Stroke (2013) 0.94
DNA microarray analysis of the correlation between gene expression patterns and acquired resistance to 5-FU/cisplatin in gastric cancer. Biochem Biophys Res Commun (2004) 0.94
A phase II study of weekly docetaxel plus capecitabine for patients with advanced nonsmall cell lung carcinoma. Cancer (2003) 0.94
Chronic rhinosinusitis with polyps and without polyps is associated with increased expression of suppressors of cytokine signaling 1 and 3. J Allergy Clin Immunol (2013) 0.94
Effects of Helicobacter pylori eradication in patients with immune thrombocytopenic purpura. Korean J Hematol (2010) 0.94
Prognostic implications of genetic variants in advanced non-small cell lung cancer: a genome-wide association study. Carcinogenesis (2012) 0.94
Association of CYP2A6 polymorphisms with S-1 plus docetaxel therapy outcomes in metastatic gastric cancer. Pharmacogenomics (2009) 0.94
Functional recovery after spinal cord injury in dogs treated with a combination of Matrigel and neural-induced adipose-derived mesenchymal Stem cells. Cytotherapy (2012) 0.93
Non small cell carcinoma metastasis to meningioma. J Korean Neurosurg Soc (2013) 0.93
Novel polymorphisms in the SUV39H2 histone methyltransferase and the risk of lung cancer. Carcinogenesis (2006) 0.93
Risk for leptomeningeal seeding after resection for brain metastases: implication of tumor location with mode of resection. J Neurosurg (2012) 0.92
Herpesviridae viral infections after chemotherapy without antiviral prophylaxis in patients with malignant lymphoma: incidence and risk factors. Am J Clin Oncol (2012) 0.92
Population-based survival data for brain tumors in Korea. J Neurooncol (2012) 0.92
Weekly docetaxel in combination with capecitabine in patients with metastatic gastric cancer. Am J Clin Oncol (2005) 0.92
Depression Among HIV-infected Patients in Korea: Assessment of Clinical Significance and Risk Factors. Infect Chemother (2013) 0.91
Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small-cell lung cancer: report of a randomized comparative trial. Int J Radiat Oncol Biol Phys (2004) 0.91
Combined effects of genetic polymorphisms in six selected genes on lung cancer susceptibility. Lung Cancer (2007) 0.91
Atypical pathogens as etiologic agents in hospitalized patients with community-acquired pneumonia in Korea: a prospective multi-center study. J Korean Med Sci (2006) 0.91
A randomized phase II study of gefitinib plus simvastatin versus gefitinib alone in previously treated patients with advanced non-small cell lung cancer. Clin Cancer Res (2011) 0.91